%). This promising growth was due to more subspecialties as well as capacity expansion. OPD increased by 3 units and IPD increased by 17 units yoy. Number of OPD patients remained on the rise while revenue
together with a rise in revenues from sales of wellness and anti-aging Business Unit at Baht 128.58 million or increase of Baht 34.12 million or 26.54% in 2019 largely from sales of probiotic products such
www.interpharma.co.th Inter Pharma Co. Ltd. 140/9 ITF Tower, 9th Floor, Silom Road, Suriyawong, Bangrak, Bangkok 10500, Thailand. Tel. 02-634-0225 Fax 02-634-0135 www.interpharma.co.th a surge in revenues from sales of
& vaccination) was on par with the previous year. This trend also incurred to IPD income with IPD visit number barely changed yoy. while revenue per visit has increased by 10% yoy. The increase of revenue per
% growth of revenue from sales of house and condominium units and 71% increase in revenue from rental and services attributed to the rise of total revenue. 2Q19 Net profit at THB 192m, or 56% decline YoY
8,875m, increased by 128% YoY. Major drivers of such growth were 298% increase in revenue from sales of house and condominium together with 38% increase in revenue from rental and services which mainly
”) reported 2019 total revenue of THB 12,275m, increased by 63% YoY. Major drivers of such growth were 104% increase in revenue from sales of house and condominium together with 27% increase in revenue from
marketing margin declined from the rise in crude oil price in Q1/2019, which caused the finished oil products cost to increase, while the retail price was slower to adjust. Moreover, with the price fix for
March 2018 increased by 19% yoy mainly from the surge of provisions for employee benefit and other liabilities. Most of the increase of other liabilities was income tax payable on 2017 profit because